Investing.com - Immunocore Holdings reported on Wednesday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Immunocore Holdings announced earnings per share of £-0.14 on revenue of £45.87M. Analysts polled by Investing.com anticipated EPS of £-0.24 on revenue of £32.82M.
Immunocore Holdings shares are down 16.73% from the beginning of the year and are trading at £56.20 , down-from-52-week-high.
Immunocore Holdings shares gained 1.10% in pre-market trade the report.
Immunocore Holdings follows other major Healthcare sector earnings this month
Immunocore Holdings's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of £5.79 on revenue of £80.89B, compared to forecasts EPS of £5.43 on revenue of £80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of £2.55 on revenue of £23.79B, compared to forecast for EPS of £2.52 on revenue of £23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar